Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 2 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar Clint35 (70.43) Submitted: 1/2/2013 3:33:39 PM : Underperform Start Price: $99.87 ALXN Score: +13.84

Price and expectations are way too high. This is really a small cap company that's barely gotten started. But it's being valued like a reliable big pharma company.

Featured Broker Partners


Advertisement